{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:42:39Z","timestamp":1771476159432,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T00:00:00Z","timestamp":1606003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81402116"],"award-info":[{"award-number":["No.81402116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No. 2019A1515010285"],"award-info":[{"award-number":["No. 2019A1515010285"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s00432-020-03453-x","type":"journal-article","created":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T14:02:41Z","timestamp":1606053761000},"page":"1781-1788","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor"],"prefix":"10.1007","volume":"147","author":[{"given":"Bin","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaowei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenji","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingwu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaopeng","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-5110","authenticated-orcid":false,"given":"Junxing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,22]]},"reference":[{"key":"3453_CR1","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","volume":"76","author":"M Babjuk","year":"2019","unstructured":"Babjuk M et al (2019) (2019) European Association of Urology Guidelines on non-muscle-invasive bladder cancer (TaT1 and Carcinoma In Situ)\u2014Update. Eur Urol 76:639\u2013657. https:\/\/doi.org\/10.1016\/j.eururo.2019.08.016","journal-title":"Eur Urol"},{"key":"3453_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/01.ju.0000039680.90768.b3","volume":"169","author":"A Bohle","year":"2003","unstructured":"Bohle A, Jocham D, Bock PR (2003) Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169:90\u201395. https:\/\/doi.org\/10.1097\/01.ju.0000039680.90768.b3","journal-title":"J Urol"},{"key":"3453_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.eururo.2013.07.021","volume":"65","author":"M Brausi","year":"2014","unstructured":"Brausi M et al (2014) Side effects of Bacillus Calmette-Guerin (BCG) in the treatment of intermediate- and high-risk Ta, T1 papillary carcinoma of the bladder: results of the EORTC genito-urinary cancers group randomised phase 3 study comparing one-third dose with full dose and 1 year with 3 years of maintenance. Eur Urol 65:69\u201376. https:\/\/doi.org\/10.1016\/j.eururo.2013.07.021","journal-title":"Eur Urol"},{"key":"3453_CR4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA Cancer J Clin"},{"key":"3453_CR5","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.eururo.2012.07.033","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M et al (2013) Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 63:234\u2013241. https:\/\/doi.org\/10.1016\/j.eururo.2012.07.033","journal-title":"Eur Urol"},{"key":"3453_CR6","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1007\/s00270-013-0594-2","volume":"36","author":"J Chen","year":"2013","unstructured":"Chen J, Yao Z, Qiu S, Chen L, Wang Y, Yang J, Li J (2013) Comparing intra-arterial chemotherapy combined with intravesical chemotherapy versus intravesical chemotherapy alone: a randomised prospective pilot study for T1G3 bladder transitional cell carcinoma after bladder-preserving surgery. Cardiovasc Intervent Radiol 36:1521\u20131526. https:\/\/doi.org\/10.1007\/s00270-013-0594-2","journal-title":"Cardiovasc Intervent Radiol"},{"key":"3453_CR7","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s11255-011-9941-x","volume":"43","author":"E De Berardinis","year":"2011","unstructured":"De Berardinis E, Busetto GM, Antonini G, Giovannone R, Gentile V (2011) T1G3 high-risk NMIBC (non-muscle invasive bladder cancer): conservative treatment versus immediate cystectomy. Int Urol Nephrol 43:1047\u20131057. https:\/\/doi.org\/10.1007\/s11255-011-9941-x","journal-title":"Int Urol Nephrol"},{"key":"3453_CR8","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1097\/01.ju.0000140456.42509.b6","volume":"172","author":"L Eapen","year":"2004","unstructured":"Eapen L, Stewart D, Collins J, Peterson R (2004) Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. J Urol 172:1276\u20131280. https:\/\/doi.org\/10.1097\/01.ju.0000140456.42509.b6","journal-title":"J Urol"},{"key":"3453_CR9","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1007\/s12032-014-0912-9","volume":"31","author":"B Han","year":"2014","unstructured":"Han B et al (2014) Organ preservation for muscle-invasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection. Med Oncol 31:912. https:\/\/doi.org\/10.1007\/s12032-014-0912-9","journal-title":"Med Oncol"},{"key":"3453_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1442-2042.1997.tb00292.x","volume":"4","author":"S Hoshi","year":"1997","unstructured":"Hoshi S, Mao H, Takahashi T, Suzuki K, Nose M, Orikasa S (1997) Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer. Int J Urol 4:493\u2013499. https:\/\/doi.org\/10.1111\/j.1442-2042.1997.tb00292.x","journal-title":"Int J Urol"},{"key":"3453_CR11","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00432-018-2811-5","volume":"145","author":"B Huang","year":"2019","unstructured":"Huang B et al (2019) Evaluation of the effects of intra-arterial chemotherapy combined with intravesical chemotherapy against intravesical chemotherapy alone after transurethral resection of bladder tumor in T1-staged Grade 3 bladder cancer. J Cancer Res Clin Oncol 145:487\u2013494. https:\/\/doi.org\/10.1007\/s00432-018-2811-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"3453_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00345-018-2437-x","volume":"37","author":"B Huang","year":"2019","unstructured":"Huang B, Zheng J, Yao Z, Fan W, Qiu S, Chen L, Chen J (2019) Efficacy of intra-arterial chemotherapy combined with intravesical chemotherapy in T1G3 bladder cancer when compared with intravesical chemotherapy alone after bladder-sparing surgery: a retrospective study. World J Urol 37:823\u2013829. https:\/\/doi.org\/10.1007\/s00345-018-2437-x","journal-title":"World J Urol"},{"key":"3453_CR13","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000471567","volume":"16","author":"Y Kubota","year":"1989","unstructured":"Kubota Y, Kakizaki H, Numasawa K, Suzuki K, Kato H (1989) Preoperative intra-arterial infusion chemotherapy for patients with bladder cancer. Eur Urol 16:189\u2013194. https:\/\/doi.org\/10.1159\/000471567","journal-title":"Eur Urol"},{"key":"3453_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00432-019-02900-8","volume":"145","author":"F Lian","year":"2019","unstructured":"Lian F et al (2019) Intra-arterial chemotherapy combined with intravesical chemotherapy is effective in preventing recurrence in non-muscle invasive bladder cancer. J Cancer Res Clin Oncol 145:1625\u20131633. https:\/\/doi.org\/10.1007\/s00432-019-02900-8","journal-title":"J Cancer Res Clin Oncol"},{"key":"3453_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1046\/j.1442-2042.2000.00137.x","volume":"7","author":"N Miyanaga","year":"2000","unstructured":"Miyanaga N et al (2000) A bladder preservation regimen using intra-arterial chemotherapy and radiotherapy for invasive bladder cancer: a prospective study. Int J Urol 7:41\u201348. https:\/\/doi.org\/10.1046\/j.1442-2042.2000.00137.x","journal-title":"Int J Urol"},{"key":"3453_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.ejso.2014.07.043","volume":"41","author":"Y Miyata","year":"2015","unstructured":"Miyata Y et al (2015) Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with\/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients. Eur J Surg Oncol 41:361\u2013367. https:\/\/doi.org\/10.1016\/j.ejso.2014.07.043","journal-title":"Eur J Surg Oncol"},{"key":"3453_CR17","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2012.10.039","volume":"63","author":"J Oddens","year":"2013","unstructured":"Oddens J et al (2013) Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guerin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance. Eur Urol 63:462\u2013472. https:\/\/doi.org\/10.1016\/j.eururo.2012.10.039","journal-title":"Eur Urol"},{"key":"3453_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s11934-019-0952-y","volume":"20","author":"VT Packiam","year":"2019","unstructured":"Packiam VT, Werntz RP, Steinberg GD (2019) Current clinical trials in non-muscle-invasive bladder cancer: heightened need in an era of chronic BCG shortage. Curr Urol Rep 20:84. https:\/\/doi.org\/10.1007\/s11934-019-0952-y","journal-title":"Curr Urol Rep"},{"key":"3453_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1464-410X.2012.11391.x","volume":"112","author":"IA Sternberg","year":"2013","unstructured":"Sternberg IA, Keren Paz GE, Chen LY, Herr HW, Dalbagni G (2013) Role of immediate radical cystectomy in the treatment of patients with residual T1 bladder cancer on restaging transurethral resection. BJU Int 112:54\u201359. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11391.x","journal-title":"BJU Int"},{"key":"3453_CR20","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1097\/01.ju.0000034450.80198.1c","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der Meijden AP, Lamm DL (2002) Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168:1964\u20131970. https:\/\/doi.org\/10.1097\/01.ju.0000034450.80198.1c","journal-title":"J Urol"},{"key":"3453_CR21","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013465. https:\/\/doi.org\/10.1016\/j.eururo.2005.12.031 (discussion 475-467)","journal-title":"Eur Urol"},{"key":"3453_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/01.ju.0000132129.87598.3b","volume":"172","author":"GN Thalmann","year":"2004","unstructured":"Thalmann GN, Markwalder R, Shahin O, Burkhard FC, Hochreiter WW, Studer UE (2004) Primary T1G3 bladder cancer: organ preserving approach or immediate cystectomy? J Urol 172:70\u201375. https:\/\/doi.org\/10.1097\/01.ju.0000132129.87598.3b","journal-title":"J Urol"},{"key":"3453_CR23","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/s0302-2838(03)00357-9","volume":"44","author":"AP van der Meijden","year":"2003","unstructured":"van der Meijden AP, Sylvester RJ, Oosterlinck W, Hoeltl W, Bono AV, Group EG-UTC (2003) Maintenance Bacillus Calmette-Guerin for Ta T1 bladder tumors is not associated with increased toxicity: results from a European Organisation for Research and Treatment of Cancer Genito-Urinary Group Phase III Trial. Eur Urol 44:429\u2013434. https:\/\/doi.org\/10.1016\/s0302-2838(03)00357-9","journal-title":"Eur Urol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03453-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-020-03453-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03453-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,26]],"date-time":"2021-04-26T12:10:56Z","timestamp":1619439056000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-020-03453-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,22]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3453"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03453-x","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,22]]},"assertion":[{"value":"20 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1975 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}